Gary K. Steinberg

Publication Details

  • Moyamoya in a Child Treated With Interferon for Recurrent Osteosarcoma JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY Buchbinder, D., Steinberg, G., Linetsky, M., Casillas, J. 2010; 32 (6): 476-478

    Abstract:

    Moyamoya is a cerebral vasculopathy of unknown etiology rarely described as a late effect after the treatment of childhood cancer. We describe a 12-year-old female who developed moyamoya after the completion of systemic chemotherapy, surgery, and adjuvant interferon alpha for osteosarcoma with pulmonary metastases. Given the importance of characterizing late effects after the treatment of childhood cancer, the potential role of interferon alpha in the development of moyamoya is discussed.

    View details for DOI 10.1097/MPH.0b013e3181e5e1db

    View details for Web of Science ID 000280666100007

    View details for PubMedID 20562650

Stanford Medicine Resources:

Footer Links: